Medical reprocessing market sees renewed growth as healthcare providers face pressures to manage costs and increase sustainability
The global medical sterilization, repair, and refurbishment industry is expected to reach $6.93 billion by 2021 from $4.69 billion in 2016, at a CAGR of 8.8%.1
Our medical reprocessing index has generally tracked the growth of the S&P 500 index since 2012. In the last three years the S&P index has increased 37%, while our medical reprocessing index has increased 45%.
Median revenue multiples in the public markets are currently tracking at a median of 2.1x, while EBITDA multiples have a median of 21.1x, showing stable performance compared to the last year with 1.8x and 19.4x respectively.
Transaction multiples, as are typical, are tracking in a somewhat lower range, with median revenue multiples of 1.7x and median EBITDA multiples of 9.0x over the past three years.